Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omniab Inc (OABI)

Omniab Inc (OABI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 280,712
  • Shares Outstanding, K 143,955
  • Annual Sales, $ 18,670 K
  • Annual Income, $ -64,780 K
  • EBIT $ -56 M
  • EBITDA $ -35 M
  • 60-Month Beta 0.13
  • Price/Sales 14.58
  • Price/Cash Flow N/A
  • Price/Book 1.02

Options Overview Details

View History
  • Implied Volatility 185.74% (-247.84%)
  • Historical Volatility 53.45%
  • IV Percentile 38%
  • IV Rank 13.36%
  • IV High 1,055.70% on 11/12/25
  • IV Low 51.61% on 03/31/25
  • Expected Move (DTE 10) 0.6375 (31.48%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 876
  • Open Int (30-Day) 872
  • Expected Range 1.3875 to 2.6625

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.10
  • Number of Estimates 3
  • High Estimate -0.09
  • Low Estimate -0.11
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +41.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6350 +23.24%
on 02/12/26
2.0600 -2.18%
on 03/05/26
+0.2850 (+16.47%)
since 02/10/26
3-Month
1.6350 +23.24%
on 02/12/26
2.2200 -9.23%
on 12/12/25
+0.0150 (+0.75%)
since 12/10/25
52-Week
1.2200 +65.16%
on 05/30/25
3.3400 -39.67%
on 03/17/25
-1.2350 (-38.00%)
since 03/10/25

Most Recent Stories

More News
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Conference Call Begins at 4:30 p.m. Eastern Time Today

OABI : 2.0300 (+4.10%)
OmniAb to Participate at the Leerink Partners Global Healthcare Conference

OmniAb, Inc. (NASDAQ: OABI) today announced that management will participate at the Leerink Global Healthcare Conference taking place March 8-11, 2026, at the W South Beach in Miami. Management...

OABI : 2.0300 (+4.10%)
OmniAb to Report Fourth Quarter 2025 Financial Results on March 4

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the quarter and year ended December 31, 2025, after the close of the U.S. financial markets on Wednesday, March 4, 2026, and will hold...

OABI : 2.0300 (+4.10%)
Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

First and only transgenic chicken platform engineered to express ultralong CDRH3 domains on a human antibody framework broadens therapeutic opportunities beyond conventional antibodies ...

OABI : 2.0300 (+4.10%)
OmniAb to Hold OmniUltra Virtual Investor Event on December 15

OmniAb, Inc. (NASDAQ: OABI) today announced it will hold a virtual investor event to showcase the launch of OmniUltra ™ on Monday, December 15, 2025, beginning at 5:00 p.m. Eastern...

OABI : 2.0300 (+4.10%)
AI Spending in Healthcare and Wellness Triples as Personalized Wellness Platforms Scale

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – Healthcare's artificial intelligence transformation is accelerating at unprecedented speed, with AI spending hitting...

OPRX : 6.92 (+1.17%)
CTSH : 63.24 (-2.18%)
CERT : 6.88 (-2.27%)
OABI : 2.0300 (+4.10%)
ALEN-U.CN : 1.1500 (unch)
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

Agreement is focused on Omni dAb™ single domain technology OmniAb to receive revenue for discovery services as well as potential equity and royalties

OABI : 2.0300 (+4.10%)
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today

OABI : 2.0300 (+4.10%)
OmniAb to Participate in Three Investor Conferences in November

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three investor conferences during the month of November. 2025...

OABI : 2.0300 (+4.10%)
OmniAb to Report Third Quarter 2025 Financial Results on November 4

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and nine months ended September 30, 2025, after the close of the U.S. financial markets on Tuesday, November 4, 2025, and...

OABI : 2.0300 (+4.10%)

Business Summary

OmniAb Inc. discovery platform provides pharmaceutical industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. OmniAb Inc., formerly known as Avista Public Acquisition Corp. II, is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 2.1667
2nd Resistance Point 2.0633
1st Resistance Point 2.0067
Last Price 2.0300
1st Support Level 1.8467
2nd Support Level 1.7433
3rd Support Level 1.6867

See More

52-Week High 3.3400
Fibonacci 61.8% 2.5302
Fibonacci 50% 2.2800
Last Price 2.0300
Fibonacci 38.2% 2.0298
52-Week Low 1.2200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar